Related Experiment Video
Updated: Dec 27, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
CpG Oligodeoxynucleotides Induces Apoptosis of Human Bladder Cancer Cells via Caspase-3-Bax/Bcl-2-p53 Axis
Yang Luo1, Xiaoyi Fu1, Ruizhen Ru1
1School of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Objective:
To evaluate the anti-cancer effect of unmethylated cytosine-phosphorothioate-guanine (CpG)-containing oligodeoxynucleotides (ODNs) on human bladder cancer UM-UC-3 cells, our study was carried out.
Methods:
The viability of cells (UM-UC-3, T24 and SV-HUC-1) with CpG ODN treatments was examined by cell counting kit-8 (CCK-8) assay. Apoptosis and cell cycle phase were determined by flow cytometry analysis. Pre-apoptosis factors of caspase-3, p53, B-cell lymphoma 2 associated X protein (Bax) and anti-apoptosis factor of B-cell lymphoma 2 (Bcl-2) were detected by western blot.
Results:
Experimental results showed that the viability of human bladder cancer cells (UM-UC-3 and T24) with CpG ODN treatment was decreased and the viability of human normal urothelial cells (SV-HUC-1) with CpG ODN treatment was increased with time-dependance manner. Moreover, CpG ODN increased the apoptosis rate of UM-UC-3 cells and arrested more cells in G0G1 phase. Furthermore, the expression of caspase-3, p53 and Bax were increased and the expression of Bcl-2 was decreased with CpG ODN treatment on UM-UC-3 cells.
Conclusion:
CpG ODN promoted the proliferation of normal urinary transitional epithelial cells (SV-HUC-1) and inhibited the cell viability of human bladder cancer cells (UM-UC-3 and T24) in vitro. CpG ODN induced the apoptosis of human bladder cancer (UM-UC-3) cells in a cascade progress via enhancing the expression of caspase-3, p53 and Bax, and inhibiting the expression of Bcl-2 with significant time-dependancy. CpG ODN inhibited cell cycle distribution of human bladder cancer (UM-UC-3) cells with more cells were arrested in G0G1 phase. This study suggested that the CpG ODN is the potential candidate on human bladder cancer.
Insights
Unmethylated cytosine-phosphorothioate-guanine (CpG) oligodeoxynucleotides (ODNs) show anti-cancer effects on human bladder cancer cells by decreasing viability and increasing apoptosis. CpG ODNs also promote normal urothelial cell proliferation, suggesting potential therapeutic applications.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Bladder cancer remains a significant health concern.
- Oligodeoxynucleotides (ODNs) containing unmethylated cytosine-phosphorothioate-guanine (CpG) motifs are known to activate immune responses.
- The specific anti-cancer effects of CpG ODNs on human bladder cancer cells require further elucidation.
Purpose of the Study:
- To investigate the anti-cancer effects of CpG ODNs on human bladder cancer cell lines.
- To evaluate the impact of CpG ODNs on cell viability, apoptosis, and cell cycle progression.
- To analyze the expression of key apoptosis-related proteins.
Main Methods:
- Human bladder cancer cell lines (UM-UC-3, T24) and normal urothelial cells (SV-HUC-1) were treated with CpG ODNs.
- Cell Counting Kit-8 (CCK-8) assay was used to assess cell viability.
- Flow cytometry was employed to determine apoptosis rates and cell cycle distribution.
- Western blot analysis was performed to detect the expression of caspase-3, p53, Bax, and Bcl-2.
Main Results:
- CpG ODN treatment significantly decreased the viability of human bladder cancer cells (UM-UC-3, T24) in a time-dependent manner.
- CpG ODNs increased the apoptosis rate and induced G0G1 phase arrest in UM-UC-3 cells.
- The expression of pro-apoptotic factors (caspase-3, p53, Bax) was upregulated, while the anti-apoptotic factor (Bcl-2) was downregulated in UM-UC-3 cells upon CpG ODN treatment.
- CpG ODNs promoted the proliferation of normal urothelial cells (SV-HUC-1).
Conclusions:
- CpG ODNs exhibit a dual effect, inhibiting bladder cancer cell viability while promoting normal urothelial cell proliferation.
- CpG ODNs induce apoptosis in human bladder cancer cells through a cascade involving caspase-3, p53, and Bax, and downregulating Bcl-2.
- CpG ODNs affect cell cycle distribution, leading to G0G1 phase arrest in bladder cancer cells.
- CpG ODNs represent a potential therapeutic candidate for human bladder cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
Abnormal Proliferation

